Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study-Reference-Cited by-同舟云学术

Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study

Published:2024-06-07 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Zhao Liang,Wu Fanghao,Wang JinJin,Wang Yuxin,Peng Wei,Chen Yuqin

Funder

the Medical Scientific research project of Chongqing Municipal Health Commission

Excellent Youth Program of the Basic Medical college of Chongqing Medical University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-024-05084-0.pdf

Reference24 articles.

1. Lightner DJ, Gomelsky A, Souter L, Vasavada SP (2019) Diagnosis and treatment of overactive bladder (Non-Neurogenic) in adults: AUA/SUFU Guideline Amendment 2019. J Urol 202:558–563

2. Griebling TL (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence, and bladder outlet obstruction. BJU Int 108:1138–1139

3. Raju R, Linder BJ (2020) Evaluation and Treatment of Overactive Bladder in Women. Mayo Clin Proc. ;95:370–7

4. Nambiar AK, Arlandis S, Bø K, Cobussen-Boekhorst H, Costantini E, de Heide M et al (2022) European Association of Urology Guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol 82:49–59

5. Scott K, Dmochowski RR, Padmanabhan P (2016) Delivery methods for drugs used in the treatment of overactive bladder. Expert Opin Drug Deliv 13:361–371